Poor Ovarian Reserve Clinical Trial
Official title:
Effects of Autologous Intraovarian Platelet Rich Plasma in Women With Poor Ovarian Response
Reproductive age women diagnosed with poor ovarian response (POR) based on Bologna criteria with a history of at least two prior failed ICSI cycle will be recruited for the study. Antral follicle count (AFC), serum anti-mullerian hormone (AMH), and early follicular phase serum follicle stimulating hormone (FSH) levels will determined at baseline. Autologous blood obtained from peripheral vein will be used to prepare PRP following standard protocols and will be injected to both ovaries. Ovarian reserve parameters and ICSI outcomes will be determined.
Reproductive age women diagnosed with POR based on Bologna criteria with a history of at least two prior failed intracytoplasmic sperm injection (ICSI) cycle will recruited for the study. Antral follicle count (AFC), serum anti-mullerian hormone (AMH), and early follicular phase serum follicle stimulating hormone (FSH) levels will be determined at baseline. Autologous blood obtained from peripheral vein will be used to prepare PRP following standard protocols. PRP injection will be performed under sedation anesthesia, using a 11.8 inch (30 cm) single lumen 21G needles under transvaginal ultrasound guidance. On the 2 to 4th days of the first three menstrual cycles following the procedure, AFC, AMH, and FSH levels will be re-assessed. Patients with at least one antral follicle will be started on ovarian stimulation for ICSI, followed by embryo transfer. Biomarkers of ovarian reserve (AFC, FSH, AMH), and ICSI outcome parameters (number of metaphase II (MII) oocytes, blastocyst embryos, fertilization rate, oocyte and embryo quality) will be followed. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01204840 -
Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)
|
Phase 2 | |
| Completed |
NCT04224818 -
Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders
|
Phase 3 | |
| Recruiting |
NCT05602090 -
Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04588844 -
Effect of Growth Hormone Injection on the IVF/ICSI Outcome of Patients With Poor Ovarian Reserve.
|
N/A |